Clinical evidence
Eight independent studies and guidelines on low-level laser therapy. Every one links to the full published paper, so nothing here has to be taken on trust.
American College of Physicians
The ACP's 2017 clinical practice guideline for low back pain lists low-level laser therapy among the non-pharmacologic treatments for chronic low back pain, in a guideline that recommends starting with non-drug treatment before medication.
Annals of Internal Medicine, April 2017The Lancet
A 2009 review reported that LLLT reduced pain immediately after treatment in acute neck pain, and for up to 22 weeks after treatment ended in patients with chronic neck pain.
The Lancet, December 2009Photomedicine and Laser Surgery
A systematic review of 14 studies on low-level laser therapy. B-Cure Laser was the device used in 4 of the 14, accounting for 29% of all patients across the reviewed research.
Photomedicine and Laser Surgery, November 2018University of Parma, Italy
A 50% reduction in acute and chronic pain within two weeks, compared with 8% in the control group.
Published in Laser Therapy, March 2015Sapienza University of Rome, Italy
90 patients across three groups: active laser, placebo laser and pain medication. Pain reduction from the active laser was statistically significant against placebo, and no different from the medication group.
Published in Cranio, April 2019Hadassah Hospital
Twelve weeks of daily treatment significantly decreased wound size in diabetic foot ulcers. 70% of the treated group reached over 90% wound closure, against 11% of controls.
Beneficência Portuguesa Hospital, São Paulo
Patients recovering from back surgery showed reduced temperature at the surgical site, lower drainage output, less pain and faster healing than controls. Significance for pain: p<0.001.
American Society for Laser Medicine and Surgery, 2014Holy Family Hospital
Self-applied photobiomodulation after rotator cuff arthroscopic surgery significantly accelerated pain reduction at both three and six months.
Lasers in Surgery and Medicine, 2023The ACP guideline and The Lancet review assess low-level laser therapy as a treatment category rather than any single device. The systematic review is the one that names B-Cure Laser specifically. The manufacturer's full research library is at bcurelaser.com/clinical-trials.
B-Cure Laser Pro
The device studied across this research, built for daily use at home.
See the device and pricingB-Cure Laser is a medical device cleared by the U.S. FDA under the 510(k) pathway for the temporary relief of muscle and joint pain, arthritis pain and muscle spasm. Results vary from person to person. This page is not a substitute for medical advice. B-Cure Laser® is a registered trademark; all rights in its studies and clinical materials are reserved to B-Cure Laser.